ASPIRIN; OMEPRAZOLE

Pre-LaunchSM

aspirin; omeprazole

ANDAORALTABLET

Lifecycle

Pre-Launch

Data completeness

2/8 — Basic

ASPIRIN; OMEPRAZOLE (aspirin; omeprazole) by Teva is (acetylsalicylic acid) is an inhibitor of both prostaglandin synthesis and platelet aggregation. Approved for gastrointestinal bleeding due to aspirin.

Drug data last refreshed 1mo ago

Mechanism of Action

(acetylsalicylic acid) is an inhibitor of both prostaglandin synthesis and platelet aggregation. The differences in activity between aspirin and salicylic acid are thought to be due to the acetyl group on the aspirin molecule. This acetyl group is responsible for the inactivation of cyclo-oxygenase…

Indications (1)

gastrointestinal bleeding due to aspirin

Worked on ASPIRIN; OMEPRAZOLE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.